Skip to content
Recall Observatory FDA recall evidence

Drug product

Brimonidine Tartrate Opthalmic Solution 0.2%, 15 mL bottle, Rx only, Manufactured for: Somerset Therapeutics, LLC Hollywood, FL 33024. Made in India. NDC 70069-233-01

D-1375-2020

June 04, 2020

Class III

Product summary

Firm
SOMERSET THERAPEUTICS LLC
Event
Event 85826
Status
Terminated
Classification
Class III
Quantity
22,788 bottles
Official record key
drug-enforcement:D-1375-2020

Official wording

Reason: Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

Code information: Lot #s BRM13W9001, BRM13W9002, BRM13W9003, EXP Dec. 2020: BRM13W9004, EXP Apr. 2021.

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specification